Company / Capital Expenditures
IONIS PHARMACEUTICALS INC Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$51.4M
FY2025
5-year range
$15.7M / $51.4M
FY2021-FY2025
Trend
+13.6%
vs FY2024
Sector context
#27 of 194
Health Care
What the data says
IONIS PHARMACEUTICALS INC's capital expenditures of $51M is higher than 86% of companies in the Health Care sector (FY2025). Capital Expenditures has increased for 3 consecutive years, from $16M in FY2022 to $51M in FY2025.
Based on SEC 10-K filings.
$51M in FY2025 with a 5-year CAGR of +30.5%. Top quartile in the Health Care sector.
Improved from $24M to $51M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +48.5%
- 5-Year CAGR
- +30.5%
- 10-Year CAGR
- -
Sector benchmark
-56.2% below sector average
Key checks
Key Insights
- IONIS PHARMACEUTICALS INC's capital expenditures has grown for 3 consecutive years.
- 5-year CAGR of +30.5%, indicating consistent growth.
- In FY2025, capital expenditures increased 13.6% year-over-year.
- Ranks #27 out of 194 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $51.4M | +13.6% |
| FY2024 | $45.3M | +90.2% |
| FY2023 | $23.8M | +51.4% |
| FY2022 | $15.7M | -49.1% |
| FY2021 | $30.9M | +127.1% |
| FY2020 | $13.6M | -60.9% |
| FY2019 | $34.8M | +389.2% |
| FY2018 | $7.1M | -79.6% |
| FY2017 | $34.8M | +389.2% |
| FY2016 | $7.1M | -7.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026